BallsM., BlaauboerB.J., FentemJ.H., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA23, 129–147.
2.
CurrenR.D., SoutheeJ.A., SpielmannH., LiebschM., FentemJ.H., & BallsM. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA23, 211–217.
3.
BallsM., & KarcherW. (1995). The validation of alternative test methods. ATLA23, 884–886.
4.
BallsM., & FentemJ.H. (1997). Progress toward the validation of alternative tests. ATLA25, 33–43.
5.
BallsM., & FentemJ.H. (1999). The validation and acceptance of alternatives to animal testing. Toxicology in Vitro13, 837–846.
6.
WorthA.P., & BallsM. (2001). The importance of the prediction model in the development and validation of alternative tests. ATLA29, 135–143.
